Urapidil Stragen i.v. 25 mg solution for injection.
Urapidil Stragen i.v. 50 mg solution for injection.
Urapidil Stragen i.v. 100 mg concentrate for solution for infusion.
| Pharmaceutical Form |
|---|
|
25 mg/50 mg: Solution for injection, which could also be diluted for infusion purposes. 100 mg: Concentrate for solution for infusion. Clear, colourless solution with a pH of 5.6 to 6.6. Free from visible particles. |
1 ml contains 5 mg urapidil.
5 ml ampoule contains 25 mg urapidil.
10 ml ampoule contains 50 mg urapidil.
20 ml ampoule contains 100 mg urapidil.
For the full list of excipients, see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Urapidil |
Urapidil is a α1-adrenoceptor antagonist and 5-HT1A receptor agonist and consequently inhibits the vasoconstrictor effect of catecholamines. It interacts with peripheral α1-adrenoceptors and central 5-HT1A receptors to produce vasodilation without sympathetic activation. |
| List of Excipients |
|---|
|
Propylene glycol |
Ampoules of clear glass (type I Ph. Eur.)
Pack size: 5 ampoules.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
